Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Preclinical comparison of regorafenib and sorafenib efficacy for hepatocellular carcinoma using multimodality molecular imaging

Preclinical comparison of regorafenib and sorafenib efficacy for hepatocellular carcinoma using... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cancer Letters Unpaywall

Preclinical comparison of regorafenib and sorafenib efficacy for hepatocellular carcinoma using multimodality molecular imaging

Liu, Shengnan; Du, Yang; Ma, He; Liang, Qian; Zhu, Xu; Tian, Jie
Cancer Letters – Jul 1, 2019
Download PDF
Loading next page...
 
/lp/unpaywall/preclinical-comparison-of-regorafenib-and-sorafenib-efficacy-for-9022yaRt5o

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Unpaywall
ISSN
0304-3835
DOI
10.1016/j.canlet.2019.03.037
Publisher site
See Article on Publisher Site

Abstract

Journal

Cancer Letters – Unpaywall

Published: Jul 1, 2019

There are no references for this article.